Using tissue microarray and immunohistochemistry, Suzuki and colleagues found that tumor interleukin-12 receptor β2 (IL-12Rβ2), IL-7R, and stromal FoxP3/CD3 ratio are independent predictors of recurrence in patients with stage I lung adenocarcinoma [14]. This evidence concerns the gene IL7R and lung adenocarcinoma.